關於我們
Apex AI Institute Inc. 是一家依據紐約州非營利法人法組織成立的國內非營利法人。
創始董事——Dr. Lun-Hsiang Yuan 及 J. Michael Hwang——皆為無償任職。他們的專業背景涵蓋泌尿腫瘤學、機器人手術、臨床 AI 系統、企業財務及組織治理。
目前聚焦於兩項公益支柱：加速藥物開發研究（計畫 A）及社區可及的醫療 AI 教育（計畫 C 與 D）。其他願景方向為未來工作；詳見 我們的使命 以了解全貌。
我們以公益孵化器模式運作：公益研究成果留在 AAI 內部；若某項專案發展為具有商業潛力之項目，則可能分拆為獨立組織的營利實體。任何此類轉換均須經董事會以公平市場價格條件核准，並完整載入紀錄。
How we work
The operating posture behind every program — built by the people who teach it, shared without fee, replicable by anyone.
Programs are designed by the directors who will teach and publish them — not outsourced to third-party curriculum vendors.
Every collaboration — academic, community, or institutional — is non-exclusive. Partners can replicate anything we build.
Syllabi, code, recordings, and methods manuscripts ship under permissive licenses, with no paywall or approval gate.
Meet a director
Deputy Director of Urology, National Taiwan University Hospital, Yunlin Branch
Robotic urologic surgeon and clinical-AI researcher. Leads Asia's highest-volume Senhance robotic surgery program and co-leads AAI's Applied AI Literacy program. First author of the 2025 WJMH paper on LLM-based prostate-cancer risk assessment.
See the full board →